Global Endoscopic Ultrasound Needles Market Size was valued at USD 0.16 Billion in 2023. The Endoscopic Ultrasound Needles Market industry is projected to grow from USD 0.17 Billion in 2024 to USD 0.27 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2024 - 2032). The high growth of the healthcare industry, the rising aging population, and the increasing importance of early diagnosis of cancer are expected to be significant market drivers for the endoscopic ultrasound needles market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for Endoscopic Ultrasound Needles is driven by the rising prevalence of cancer and growing research studies for cancer diagnosis and treatment. As per a report published in PubMed in June 2021 for an observational study involving 800 patients enrolled for 18 months, 771 were analyzed to determine the effect of rapid on-site evaluation (ROSE) on the diagnostic accuracy of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB). A 96.4% accuracy was achieved among 385 morphologic samples that used the rapid on-site evaluation (ROSE) analysis method. After the trial, the remaining 386 people without ROSE were 97.4%, with an absolute risk difference of 1.0%. The study has proven that the endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) demonstrated high accuracy in all the solid pancreatic lesions (SPLs). Solid Pancreatic lesions (SPL) overall comprise adenocarcinoma, Neuroendocrine tumors, cystic pancreatic neoplasms (CPN) with solid components, solid pseudo-papillary tumors (SPT), pancreatic lymphoma, and metastasis.
The World Health Organization has projected that in 2022 alone, more than 20 million cases and approximately 9.7 million deaths were attributable to TB, as per the most recent data available. The projections were estimated that throughout the world, 53.5 million people would be alive for the next five years after the cancer diagnosis. According to studies, cancer in a lifetime proceeds to diagnosis in 20% of people on average, while there is a greater chance of 1 in 9 men and 1 in 11 women to get diagnosed. Cancer is a reason for many deaths. Biologically, leukemia stands first among all types of cancers in both sexes for the age group below 14 in India, which had a prevalence between 46.4% and 44.3% of boys and girls in 2021, respectively. The most identifying characteristic of childhood cancer in boys is lymphoma, and 16.4% of the cases in girls are a malignant bone tumor, with 8.9%. As a result, it is anticipated that throughout the projection period, demand for the Endoscopic Ultrasound Needles Market will increase due to the rising prevalence of cancer, as well as growing research studies for cancer diagnosis and treatment. Thus, driving the Endoscopic Ultrasound Needles Market revenue.
The global Endoscopic Ultrasound Needles Market segmentation, based on Product, includes Aspiration Needles (EUS-FNA) and Biopsy Needles (EUS-FNB). The Biopsy Needles (EUS-FNB) segment dominated the market, accounting for 58% of market revenue. Following the multiple product utilization connected to an endoscopic ultrasound for multiple pancreatic lesions of lymphoma, autoimmune pancreatitis, or submucosal lesions. The regional and key market players estimate that providing financial support tends to be a key factor that stimulates research and development, and consequently, making advanced technologies available to the population is an additional driving power of this segment.
The global Endoscopic Ultrasound Needles Market segmentation, based on Application, includes Bronchial Needles and Enteral Needles. The Bronchial Needles segment dominated the market, accounting for 58% of market revenue. As patients and providers become more inclined to focus on minimally invasive procedures instead of traditional surgeries, they get eased by such things as shorter recovery times, lesser chance of complications, and enhanced patient outcomes. EUS-aided bronchial processes are the reduced invasion alternative to diagnoses and treatment of respiratory lesions, which, in turn, increases the demand for bronchial needles.
The global Endoscopic Ultrasound Needles Market segmentation, based on Users, includes Hospitals, Specialty Clinics, and Ambulatory Surgical Centres. The Hospitals segment dominated the market, accounting for 60% of market revenue. This is the reason for the elevated cases of digestive and lung diseases. In 2019 alone, around 14.8 million people in the United States experienced different digestive issues. Many people are diagnosed with these deadly illnesses, and hence, as responsible persons, they get admitted to hospitals.
Figure 1: Global Endoscopic Ultrasound Needles Market, by End-User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Endoscopic Ultrasound needle market in North America can be attributed to several key factors. The rising allocation of funds by governmental agencies to improve the healthcare system remains the factor that can cause an increase in the healthcare market size. In Angola, the government increased the healthcare budget from USD 387 million to USD 400 million, which aimed to make access to healthcare and education affordable to about 16 million children in 2019. In 2022, U.S. healthcare expenditure widened by 4.1 percent, with the total figure recorded as $4.5 trillion or $13,493 per person. As a share of the nation’s GDP, health expenditure amounted to 17.3%. With other advanced diagnostic approaches, the gastroenterology, pulmonology, and oncology sectors in Canada and the United States will likely foster the expansion of the endoscopic ultrasound needles market in this region.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Figure 2: Global Endoscopic Ultrasound Needles Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Endoscopic Ultrasound Needles Market accounts for the second-largest market share. In Europe, healthcare spending is still growing despite economic fluctuations, mainly because of aging populations, technical improvements in medicine, and the emphasis on improving the healthcare system, among others. In 2022, social protection spending for sickness and healthcare allocated as a percentage of the GDP amounted to 8.1 % in the EU Union. Out of the 24 EU countries for which 2022 estimates are available, social protection, sickness and healthcare expenditure was most in France (10% of GDP), Germany (9.7%), Slovenia (8.6%), Austria (8.5%) and Belgium (7.8%), while it was least in Bulgaria (4.2%), Ireland (4.6%). It adds to the favorable conditions for the growth of the EUS data market. Further, the German Endoscopic Ultrasound Needles Market held the largest market share, and the UK Endoscopic Ultrasound Needles Market was the fastest-growing market in the European region.
The Asia-Pacific Endoscopic Ultrasound Needles Market is expected to grow at the fastest CAGR from 2024 to 2032. The National Institutes of Health defines that the rate, as well as high mortality of gastric cancer, is caused by high incidence of infections of helicobacter pylori, unhealthy diet, smoking, and excessive alcohol usage. In total, ∼ 1100 million new cases and 770,000 deaths of gastric cancer were seen in 2020. It was observed that incidence involved males on average 2-fold greater than females (15.8 and 7.0 per 100,000, respectively), but with different lowest and highest rates between the countries. The estimation indicated there may be as many as 4,824,700 newly reported cancer cases and 2,574,200 cancer deaths in China in 2022. Consequently, the rise in the incidence rates of gastric cancer in the highlighted region ensures market expansion. Moreover, China’s Endoscopic Ultrasound Needles Market held the largest market share, and the Indian Endoscopic Ultrasound Needles Market was the fastest-growing market in the Asia-Pacific region.
Endoscopic Ultrasound Needles Market Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Endoscopic Ultrasound Needles market grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Endoscopic Ultrasound needle industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Endoscopic Ultrasound needle industry to benefit clients and increase the market sector. In recent years, the Endoscopic Ultrasound needle industry has offered some of the most significant advantages to medical practitioners and patients alike. Major players in the Endoscopic Ultrasound Needles Market, including Olympus Corporation, Medtronic, Cook Group, Boston Scientific Corporation, CONMED Corporation, Medi-Globe GmbH, ACE Medical Devices Pvt. Ltd is attempting to increase market demand by investing in research and development operations.
Olympus Corporation is a manufacturer of precision machinery and devices for digital and optics technologies. Thus, the company is engaged in the development, manufacturing, and marketing of a wide range of medical, hospital, radiological, information, and industrial equipment and products. It does after-sales care technical support supervision, which includes medical solutions like endotherapy devices, endoscopes, endoscopy products, laser scanning microscopes, industrial and biological microscope systems, as well as out-perform visual inspection products and non-destructive systems. Similarly, it ensures the availability of biomedical materials and offers system development services. Through its subsidiaries and facilities, the company is located in the United States, Europe, and Asia, respectively. Olympus Corporation is located in Tokyo City, Japan. In April 2016, Olympus offered Single Use Aspiration Needle EZ Shot 3 Plus, its additional endoscopic ultrasound needle device within its acclaimed gastrointestinal portfolio. The existence of the newly designed needle has brought a drastic change in accessing the pancreatic protein head because of its superior flexibility.
Medtronic is a medical technology firm that specializes in the design, development, manufacturing, and marketing of medical devices and solutions. It extends a range of products for valvular heart disease treatment, heart failure, coronary artery disease, aortic, peripheral vascular, and venous system diseases, renal and neurological disorders, spine and musculoskeletal diseases, and diseases of the ear, nose, and throat. Also, the company renders biologic solutions for orthopedic and dental markets. It enables sales of its products to the health sector players, such as hospitals, pharmacies, clinics, public healthcare programs, distributors, and group purchasing organizations in the Asia Pacific, Europe, the Americas, the Middle East, and Africa. Medtronic has a central location in Dublin, Ireland.
Key companies in the Endoscopic Ultrasound Needles Market include
Endoscopic Ultrasound Needles Industry Developments
October 2023: Olympus Corporation, a major manufacturer of optical and digital precision technology, launched the latest generation of endoscopy system EVIS X1. The technique that is being referred to includes the use of narrow-band imaging and its application in rendering a more comprehensive view of mucosal and vascular processes.
September 2023: Limaca Medical, a company endoscopic ultrasound-guided biopsy on a global basis, cleared the 510(k) of the Federal Drugs Administration or the USA for its Precision GI Endoscopic Ultrasound (EUS) Biopsy Device. Precision GI obtains biopsies for definitive pancreatic cancer and other deadly GI cancer diagnoses more speedily and less traumatically.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.16 Billion |
| Market Size 2024 | USD 0.17 Billion |
| Market Size 2032 | USD 0.27 Billion |
| Compound Annual Growth Rate (CAGR) | 6.80% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea |
| Key Companies Profiled | Olympus Corporation, Medtronic, Cook Group, Boston Scientific Corporation, CONMED Corporation, Medi-Globe GmbH, ACE Medical Devices Pvt. Ltd |
| Key Market Opportunities | Technological advancements in cancer treatments |
| Key Market Dynamics | Rising Prevalence of Chronic Diseases |
Frequently Asked Questions (FAQ) :
The global Endoscopic Ultrasound Needles Market size was valued at USD 0.16 Billion in 2023.
The global Endoscopic Ultrasound needle market is projected to grow at a CAGR of 6.80% during the forecast period 2024-2032.
North America had the largest share of the global market.
The key players in the market are Olympus Corporation, Medtronic, Cook Group, Boston Scientific Corporation, CONMED Corporation, Medi-Globe GmbH, ACE Medical Devices Pvt. Ltd, and others.
The Biopsy Needles (EUS-FNB) segment dominated the market in 2023.
The Hospitals segment had the largest share in the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
